The University of Chicago Header Logo

Connection

Harvey M. Golomb to Time Factors

This is a "connection" page, showing publications Harvey M. Golomb has written about Time Factors.
Connection Strength

0.072
  1. Duration of response after interferon treatment of hairy cell leukemia. Blood. 1990 Jun 15; 75(12):2465-7.
    View in: PubMed
    Score: 0.012
  2. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia. J Natl Cancer Inst. 1988 May 04; 80(5):369-73.
    View in: PubMed
    Score: 0.010
  3. Postoperative recurrence of lung cancer: detection by whole-body gallium scintigraphy. AJR Am J Roentgenol. 1986 Nov; 147(5):911-5.
    View in: PubMed
    Score: 0.009
  4. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
    View in: PubMed
    Score: 0.009
  5. A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.
    View in: PubMed
    Score: 0.006
  6. Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
    View in: PubMed
    Score: 0.005
  7. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
    View in: PubMed
    Score: 0.002
  8. In vitro induction of proteins by alpha-interferon in hairy cell leukemia. Cancer Res. 1986 Aug; 46(8):4151-5.
    View in: PubMed
    Score: 0.002
  9. Malignant superior vena cava obstruction reconsidered: the role of diagnostic surgical intervention. Ann Thorac Surg. 1985 Sep; 40(3):285-8.
    View in: PubMed
    Score: 0.002
  10. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1984 Feb; 68(2):413-5.
    View in: PubMed
    Score: 0.002
  11. Initial alkylating agent chemotherapy in a leukemic hairy cell patient. Am J Hematol. 1984 Jan; 16(1):91-4.
    View in: PubMed
    Score: 0.002
  12. Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.
    View in: PubMed
    Score: 0.002
  13. Survival of patients with localized diffuse histiocytic lymphoma. Blood. 1981 Dec; 58(6):1218-23.
    View in: PubMed
    Score: 0.002
  14. Late relapses in Hodgkin disease. Am J Hematol. 1981; 10(1):31-6.
    View in: PubMed
    Score: 0.002
  15. Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
    View in: PubMed
    Score: 0.001
  16. Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
    View in: PubMed
    Score: 0.001
  17. Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
    View in: PubMed
    Score: 0.001
  18. Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan; 39(1):342-6.
    View in: PubMed
    Score: 0.001
  19. Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med. 1974 Nov; 81(5):601-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.